The American Cancer Society MEN 2 Consortium is a group of researchers working on improving the therapy of MTC, and, in a growing number of instances, collaborating with each other to facilitate the research.
It was started in about 2010, with a very generous grant from Mrs Janet Mordecai. As at December, 2012, there are 10 researchers in the Consortium.
The Consortium is led by Dr Herb Chen, Layton Rikkers Professor of Surgery at the University of Wisconsin. Dr Chen has an extensive basic and translational research program in MTC, as well as his clinical interest in MTC.
With grateful thanks to Dr Barry Nelkin, Professor of Oncology, Johns Hopkins University School of Medicine, for providing these updates.
Links: American Cancer Society
Information Input: January 2013